Kolinpharma® has been confirmed once more “Growth Leader”, among the 500 Italian companies that stood out for the greatest growth in the 2020-2023 observation period, marking a turnover CAGR of 24.02%, up 8 percentage points compared to to the previous three-year observation period.

This is a list of the 500 Italian companies with the highest growth in sales performance in the three-year period 2020-2023 that have joined the tender announced by Sole 24 Ore and Statista.

The criteria considered:

- Net Sales of at least 100 thousand euros in 2020
- Net Sales of at least 1.5 million in 2023
- Being an independent Italian reality
- Satisfy the principles of good repute

Nearly 1,000 companies applied. The data was checked by Statista.

Another important milestone that marks KOLINPHARMA's successful journey!